Exporter

Codes ATC: J01EE01
EMLc
Indication
Infectious gastroenteritis or colitis without specification of infectious agent Code ICD11: 1A70.Z
INN
Sulfamethoxazole + trimethoprim
Type de médicament
Chemical agent
Groupes d'antibiotiques
Type de liste
Liste de base (EML)
(EMLc)
Additional notes
single agent trimethoprim may be an alternative for lower urinary tract infection.
Formulations
Parenteral > General injections > IV: 80 mg + 16 mg per mL in 10 mL ampoule ; 80 mg + 16 mg per mL in 5 mL ampoule
Oral > Liquid: 200 mg + 40 mg per 5 mL oral liquid
Oral > Solid: 100 mg + 20 mg tablet ; 400 mg + 80 mg tablet ; 800 mg + 160 mg tablet (EML)
Oral > Solid > dispersible tablet: 100 mg + 20 mg (EMLc)
Historique des statuts LME
Ajouté pour la première fois en 2017 (TRS 1006)
Modifié en 2023 (TRS 1049)
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite sur les brevets.
Recommandation du comité d'experts
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended: - the addition of a new strength formulation of ceftriaxone (powder for injection: 500 mg (as sodium) in vial) to the EML and EMLc. - replacing the oral liquid formulation of azithromycin (200 mg/5 mL) with powder for oral liquid 200 mg/5 mL on the EML and EMLc. - the addition of a new strength formulation of ciprofloxacin (solid oral dosage form 100 mg (as hydrochloride)) to the EMLc. - the addition of a new strength formulation of sulfamethoxazole + trimethoprim (dispersible tablet 100 mg + 20 mg) on the EMLc.
Recommandations de la LME : Infectious gastroenteritis or colitis without specification of infectious agent